Cargando…
Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy
The Toll-like receptor 3 (TLR3) agonists as polyriboinosinic–polyribocytidylic acid (poly (I:C)) have been implicated as potential immunotherapy adjuvant for cancer whereas the exact roles of TLR3 agonists in hepatocellular carcinoma (HCC) treatment have not been clearly evaluated. In consistent wit...
Autores principales: | Feng, Yinglu, Chen, Yongan, Meng, Yongbin, Cao, Qingxin, Liu, Qun, Ling, Changquan, Wang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927531/ https://www.ncbi.nlm.nih.gov/pubmed/29721392 http://dx.doi.org/10.1080/2162402X.2018.1426434 |
Ejemplares similares
-
Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells
por: Qiu, Dong-Ze, et al.
Publicado: (2013) -
The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
por: Jiang, Han-yu, et al.
Publicado: (2022) -
Poly I:C induces collective migration of HaCaT keratinocytes via IL-8
por: Takada, Kazuhide, et al.
Publicado: (2017) -
Flower-like Composite Material Delivery of Co-Packaged Lenvatinib and Bufalin Prevents the Migration and Invasion of Cholangiocarcinoma
por: Ning, Zhouyu, et al.
Publicado: (2022) -
Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway
por: Wang, Haiyong, et al.
Publicado: (2016)